A detailed history of Alliancebernstein L.P. transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 15,210 shares of SCPH stock, worth $50,497. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,210
Previous 15,210 -0.0%
Holding current value
$50,497
Previous $66,000 4.55%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.51 - $5.21 $16,988 - $25,216
4,840 Added 46.67%
15,210 $66,000
Q3 2023

Nov 14, 2023

BUY
$7.0 - $9.82 $72,590 - $101,833
10,370 New
10,370 $73,000

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $91M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.